Duodenal and benign gastric ulcers which have been confirmed by radiological or endoscopic examination. Zollinger-Ellison syndrome Reflux oesophagitis confirmed by endoscopy, including curative treatment of erosion or ulcer associated with reflux oesophagitis.
Green Cross Corporation announced that the FDA has accepted for review the Company's Biologics License Application for IVIG SN (human...
Green Valley Pharmaceutical Co announced promising findings from a Phase III clinical trial of GV 971, a multi targeting carbohydrate-based...
Green Cross Corporation a South Korean biopharmaceutical company, announced that it has received a Complete Response Letter (CRL) from the...